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OBJECTIVE: The aim of this study was to analyse patient-reported outcomes of reduction mammoplasty among
Brazilian women.
METHODS: A total of 100 women were enrolled in this cross-sectional controlled study, 50 with breast
hypertrophy (Hypertrophy Group) and 50 who had undergone breast reduction at least six and up to 12 months
before (Mammoplasty Group). The Brazilian version of the BREAST-Qs was applied to assess patient-reported
outcomes. The module reduction/mastopexy was used, and the preoperative and postoperative versions were
applied to the hypertrophy and mammoplasty groups, respectively.
RESULTS: The mammoplasty group presented higher scores for the subscales satisfaction with breasts,
psychosocial well-being, sexual well-being and physical well-being (p=0.0001 for all of these subscales).
CONCLUSION: These results suggest that patients submitted to reduction mammoplasty are satisfied with the
outcomes and present better quality of life scores compared with women with breast hypertrophy.
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’ INTRODUCTION
The concept of breast hypertrophy goes beyond the simple
characterization of breast size. Breast hypertrophy can
be defined as an increase of the mammary gland beyond
the physiological limits, with the exception of increases
caused by injuries, haemorrhages, inflammation and pre-
gnancy (1,2).
Patients seeking breast reduction do so with the hope of
obtaining a better quality of life, with less social and sexual
embarrassment and greater ease in performing physical
activities and in finding suitable clothes (3). Women with
breast hypertrophy may suffer from low self-esteem and seek
surgery to alleviate physical and emotional discomfort (3).
Reduction mammoplasty is very effective in improving
functional, aesthetic and psychological problems, and several
studies have demonstrated its effectiveness in improving
quality of life (3-7).
According to the International Society of Aesthetic Plastic
Surgery (ISAPS), in 2016, Brazil ranked second in the ranking
of plastic surgery procedures in the world, with 1,450,020
surgeries performed. Specifically, breast reduction was the
eighth most performed surgery by plastic surgeons world-
wide, with 465,665 mammoplasties total. Of these, 78,815
were performed in Brazil. Therefore, it is important to eval-
uate the satisfaction results of Brazilian women undergoing
reduction mammoplasty (8). However, the benefits of this
procedure have rarely been quantified in an objective and
standardized manner (3,5,7).
BREAST-Qs was developed for the evaluation of results
in breast surgery, aiming to identify the best procedures for
a given patient and the procedures that provide the great-
est satisfaction (9,10).The objective of this controlled cross-
sectional study was to evaluate the effects of reduction
mammoplasty in Brazilian women with breast hypertrophy
from the perspective of the patients. To the best of our know-
ledge, this study is unique because it used BREAST-Qs
to compare the satisfaction and quality of life of women
submitted to reduction mammoplasty with women with
breast hypertrophy who did not seek the procedure for any
reason.
’ METHODS
This cross-sectional study was approved by the Ethics
on Research Committee of the Universidade Federal deDOI: 10.6061/clinics/2018/e313
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São Paulo under protocol 165302/12, and all participants
signed a free and informed consent form. The sample size
was estimated based on studies of other outcomes in reduc-
tion mammoplasty and was sufficient to obtain significant
results (11-13).
Fifty women with breast hypertrophy (Hypertrophy
Group, HG) defined by the criteria of Sacchini et al. and
Franco & Rebello and 50 women previously submitted to
reduction mammoplasty (Mamamoplasty Group, MG) at
least six months and at most one year prior to the study’s
initiation were selected from the plastic surgery outpatient
clinics of a university hospital (Hospital São Paulo), between
January 2014 and January 2015 (16,17).
Inclusion criteria for both groups were age between 18
and 45 years and body mass index (BMI) between 19 and
29.9 kg/m2, without restrictions regarding ethnicity, school-
ing or social class. In the HG, patients with previous breast
surgeries were not included, and in the MG, patients who
underwent mammoplasty less than six months or more
than one year prior to the study’s initiation were not
included. The exclusion criteria for both groups were illi-
teracy or inability to read and understand the applied
questionnaire, pregnancy or childbirth less than one year
ago and currently being investigated for or diagnosis of
breast disorders.
Women who met the eligibility criteria were informed
about the study and were invited to participate. After sign-
ing the informed consent, sociodemographic and clinical
data were collected, and the Brazilian version of BREAST-Qs
was self-administered.
BREAST-Qs was developed in 2009 to assess the impact
and effectiveness of breast surgeries from the patient’s
perspective. It was translated and validated for use in Brazil
in 2013 (18). The questionnaire consists of five modules –
augmentation mammoplasty, reduction mammoplasty, mas-
tectomy, breast reconstruction and conservative treatment –
and there is one version for the pre- and one for the
postoperative period. Each module is composed of indepen-
dent subscales: Physical well-being, Psychosocial well-being,
Sexual well-being, Satisfaction with breasts, Satisfaction with
nipples, Satisfaction with the overall outcome and Satisfac-
tion with the care process. The answers are transformed using
Q-Scores scoring software, with total scores ranging from
zero to 100. The higher the score is, the greater the satisfaction
or the better the quality of life (19).
Statistical analysis
For the statistical analysis, the software BioEstat 5.0 (Insti-
tuto de Desenvolvimento Sustentável Mamirauá, Belém, PA,
Brazil) was used. The non-parametric Mann-Whitney test
was used to compare the two independent groups for the
numerical variables studied. We also performed a simple
linear regression analysis to study relationships between BMI
(independent variable) and the subscale ‘‘Satisfaction with
breasts’’ (dependent variable). The level of significance was
set at 0.05 or 5%.
’ RESULTS
The groups were age-matched (p=0.284, Figure 1). MG
patients had a higher BMI (p=0.050, Figure 2), but there was
no important relationship between BMI and ‘‘Satisfaction
with breasts’’ (Figures 3 and 4). In the MG, the total weight
of resected breast tissue ranged from 280 to 3,750g (median:
830g; mean±standard deviation: 1107±834g).
Figures 5 to 8 present the comparisons between the HG
and MG with regard to the scores obtained for the four
subscales of BREAST-Qs applied to both groups (Satisfaction
with breasts, Physical well-being, Psychosocial well-being
and Sexual well-being). The MG presented better outcomes
in all of these subscales. Figure 9 presents the range and
median scores obtained for the subscales of BREAST-Qs
applied to the MG only.
’ DISCUSSION
The results in plastic surgery are evaluated in terms of
not only morbidity and mortality, but mainly patient satis-
faction, and the surgeon’s perception of the outcome is
often different from the patient’s perception (20-22). The
importance of understanding the patient’s perception about
the surgical outcome and the impact that plastic surgery
can have on the patient’s quality of life is being increasingly
recognized. This recognition has led to the development of
Figure 1 - Age of women in both groups and comparison by the Mann-Whitney test.
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instruments called PROs - Patient Reported Outcomes,
which can provide important information for health policy
decision-making (23).
The present study proposed to use a widely applied PRO
instrument, the Breast-Q, to evaluate the results of reduction
mammoplasty. Women between 18 and 45 years of age were
selected for the study. The cut-off of 18 years was chosen
to include only adult patients who could spontaneously parti-
cipate in the study and with their own consent. The 45-year
age cut-off was chosen because it was not intended to include
perimenopausal or menopausal patients because these patients
present hormonal changes that are characteristic of this period
and that may lead to alterations in sexual function, thus
interfering in the outcomes of study (24).
The BMIs of patients with breast hypertrophy are usually
higher than those of patients without hypertrophy, and the
patient’s BMI tends to be higher the greater the hypertrophy
(25,26). It was decided not to include women with BMIs
above 30 kg/m2 in any of the groups in this study, and this
eligibility criterion was the main excluding factor in the
study, which made selection difficult. However, the criterion
was maintained to minimize bias because patients with
larger BMIs present changes in their centre of gravity and
alterations in bone joints that can cause discomfort and pain,
which could be confounding factors in the results (2). In the
current study, women in the MG had higher BMIs than those
in the HG. However, the linear regression showed no impor-
tant relationships between BMI and satisfaction with breasts
in both groups.
The choice of the sixth postoperative month as the mini-
mum time to evaluate the patients in the MG was because
the eventual complications and discomfort characteristic of
Figure 2 - Body Mass Index (BMI) of women in both groups and comparison by the Mann-Whitney test.
Figure 3 - Simple linear regression for BMI (independent variable) and ‘‘Satisfaction with breasts’’ (dependent variable) in the HG.
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the postoperative period have already been overcome after
this period. After six months, the euphoria and the over-
estimation of the outcomes that usually occur soon after
surgery have stabilized (3,4,14,15). The cut-off of one year
postoperatively was established to avoid the possibility that,
in a very late evaluation, the patient no longer remembered
details of the treatment they received.
The MG presented large variations in the total weight of
resected breast tissue (280 to 3,750g). Studies have shown
that patients with breast hypertrophy usually show improve-
ment of symptoms, regardless of the volume of resected
breast tissue (15,28-30). GONZALES et al. used the BREAST-
Qs to evaluate the results of 600 patients submitted to reduc-
tion mammoplasty. They observed, as in the present study,
better outcomes in all BREAST-Qs subscales, and more than
95% of the surveyed patients were satisfied with the surgery
and would have it performed again. In addition, they
observed that BMI and breast size had no influence on
outcome (31).
The high scores of the physical well-being scale observed
in this study support what has been observed by other
authors, who verified that reduction mammoplasty was able
to promote improvements in functional capacity, back pain,
work capacity and productivity among women with breast
hypertrophy (2,27,32).
In the present study, high scores were also obtained for the
‘‘satisfaction with nipple-areolar complex’’ scale. Garcia et al.
reported that reduction mammoplasty reduced the sensitiv-
ity of the nipple-areolar complex, but did not influence sex-
ual function (33). Beraldo et al. observed a positive impact of
Figure 4 - Simple linear regression for BMI (independent variable) and ‘‘Satisfaction with breasts’’ (dependent variable) in the MG.
Figure 5 - Scores of BREAST-Qs subscale ‘‘Satisfaction with breasts’’ in both groups and comparison by the Mann-Whitney test.
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Figure 6 - Scores of BREAST-Qs subscale ‘‘Psychosocial well-being’’ in both groups and comparison by the Mann-Whitney test.
Figure 7 - Scores of BREAST-Qs subscale ‘‘Sexual well-being’’ in both groups and comparison by the Mann-Whitney test.
Figure 8 - Scores of BREAST-Qs subscale ‘‘Physical well-being’’ in both groups and comparison by the Mann-Whitney test.
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reduction mammoplasty on the sexual function of women
with breast hypertrophy, a result also corroborated by the
high scores in the sexual well-being scale found in the
present study (24). A significant portion of the Brazilian
population depends on the Brazilian public health system
(Sistema Único de Saúde - SUS), which is often the only
option for women with breast hypertrophy. Araújo et al.
studied the cost-utility relationship of reduction mammo-
plasty performed by the SUS and found that there was a
positive relationship, justifying the need to mobilize resources
for this type of procedure (34).
This study has some limitations. The main limitation is
the cross-sectional design. A prospective study, with pre and
postoperative assessment, would be able to detect the real
impact of breast reduction on patientś quality of life. Another
limitation is the lack of a group of women with normal-sized
breasts for comparison to women with breast hypertrophy and
breast reduction. However, no other study was found in the
literature using BREAST-Qs to compare the satisfaction and
quality of life of women submitted to reduction mammoplasty
with women with breast hypertrophy who did not undergo the
procedure for any reason, making this study unique.
Our results suggest that patients submitted to reduction
mammoplasty are satisfied with the outcomes and present
better quality of life scores when compared with women
with breast hypertrophy. However, prospective studies are
needed to confirm these findings.
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